Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis.
Shuwei ZhouSiyu WangJian XiangZhongyu HanWeilang WangShuhang ZhangNoble Chibuike OparaShenghong JuYing CuiYuan-Cheng WangPublished in: Abdominal radiology (New York) (2024)
ECA-MRI exhibited overall comparable diagnostic performance to EOB-MRI in assessing residual or recurrent HCC after LRT.